← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cleveland Clinic Foundation
Cleveland, OH
$217,655,441
Total funding
360
Grants
Funding over time
peak $7.9M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$201,699,228 · 323
AHRQ$9,970,555 · 12
NSF$9,590,905 · 24
CDC$1,837,295 · 3
FDA$1,111,645 · 1
SAMHSA$0 · 1
By mechanism
R01$139,600,620 · 190
P20$24,441,654 · 26
U01$13,684,118 · 7
—$9,590,905 · 24
P01$6,654,804 · 17
R21$3,359,959 · 14
Investigators at Cleveland Clinic Foundation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
GENERAL CLINICAL RESEARCH CENTER$2,912,920
M01 · FY2003 · RR
Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - Resubmission$2,324,478
P20 · FY2021 · GM
Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - Resubmission$2,264,085
P20 · FY2024 · GM
COBRE GRANT$2,262,935
P20 · FY2019 · GM
KIDNEY DISEASE/HYPERTENSION IN AFRICAN AMERICANS--DCC$2,256,662
U01 · FY2001 · DK
Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - Resubmission$2,252,411
P20 · FY2022 · GM
Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - Resubmission$2,232,255
P20 · FY2023 · GM
COBRE GRANT$2,230,641
P20 · FY2017 · GM
COBRE GRANT$2,171,415
P20 · FY2016 · GM
COBRE GRANT$2,167,171
P20 · FY2015 · GM
IFNS AND CYTOKINES--SIGNALING AND ACTION$2,043,679
P01 · FY2003 · CA
Magscrew TAH Testing thru Pre-Clinical Readiness$1,996,034
R01 · FY2002 · HL
IFNS AND CYTOKINES--SIGNALING AND ACTION$1,995,499
P01 · FY2002 · CA
Magscrew TAH Testing thru Pre-Clinical Readiness$1,970,369
R01 · FY2001 · HL
IFNS AND CYTOKINES--SIGNALING AND ACTION$1,963,207
P01 · FY2001 · CA
COBRE GRANT$1,936,240
P20 · FY2018 · GM
IFNS AND CYTOKINES--SIGNALING AND ACTION$1,916,971
P01 · FY2000 · CA
KIDNEY DISEASE/HYPERTENSION IN AFRICAN AMERICANS--DCC$1,835,274
U01 · FY2000 · DK
Collaborative Research: Frameworks: Interoperable High-Performance Classical, Machine Learning and Quantum Free Energy Methods in AMBER$1,811,050
· FY2024 · CSE
ARRA::YES::ARRA TAS::75 0850::TAS RECOVERY ACT - TISSUE SOURCE SITE (TSS) IN SUP$1,627,009
N02 · FY2010 · CA